An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A medical society called ISSCA held a certification day in São Paulo in 2026 focused on peptide therapy and regenerative medicine. The event appears to be a professional training or credentialing session rather than a single scientific study. It likely gathered clinicians and educators to teach techniques and protocols related to peptides and other regenerative approaches. When people talk about "peptides" in this context, they mean short chains of amino acids — basically tiny pieces of proteins. In medicine and wellness, some peptides are used as drugs because they can mimic or tweak natural signals in the body. For example, certain peptides can tell cells to grow, reduce inflammation, or influence metabolism. They are not pills like most drugs; many are given by injection or other medical routes and often require clinical oversight. From the title alone we can’t extract results of a study. This was a certification day, so the main "research" activity was likely teaching and demonstrating clinical techniques, reviewing evidence, and perhaps discussing case examples. These events usually mix lectures, hands-on training, and guidelines for using peptide products safely. Any claims about how well a peptide works would depend on the individual studies those presenters cited; the certification itself is about training clinicians to apply existing knowledge rather than proving new science. Why this matters to a regular person: as peptide therapies become more common in clinics, more doctors will learn how to use them. That affects access and consistency of care. If you’re considering peptide treatment for things like hormone support, fatigue, weight, or tissue repair, a certification program for providers could mean better-informed clinicians and safer procedures. It also means commercial interest is growing, so you may see more ads and clinics offering these services. Caveats and risks are important. Certification doesn’t guarantee effectiveness of the therapies themselves. Peptide products vary widely in quality, dosing, and supporting evidence. Side effects depend on the specific peptide but can include injection-site reactions, hormonal imbalances, or other unintended effects. Some peptides are experimental and not approved by major regulators for the uses clinics advertise. If you’re thinking about treatment, ask your provider for the evidence, check regulatory status, and consider established alternatives first. Bottom line: The ISSCA event in São Paulo was a professional training day about peptide and regenerative therapies — useful for clinicians, but not a substitute for rigorous clinical trials showing which peptides truly work and are safe.
Source: wir-in-kwald.de